CoChat

Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies

Open access
Petrelli, Fausto, Ghidini, Michele, Ghidini, Antonio, Perego, Gianluca, Cabiddu, Mary, Khakoo, Shelize, Oggionni, Emanuela, Abeni, Chiara, Hahne, Jens Claus, Tomasello, Gianluca, Zaniboni, Alberto · 2019 · Cancers
Cited by 106

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

The association between antibiotic use and risk of cancer development is unclear, and clinical trials are lacking. We performed a systematic review and meta-analysis of observational studies to assess the association between antibiotic use and risk of cancer. PubMed, the Cochrane Library and EMBASE were searched from inception to 24 February 2019 for studies reporting antibiotic use and subsequent risk of cancer. We included observational studies of adult subjects with previous exposure to antibiotics and available information on incident cancer diagnoses. For each of the eligible studies, data were collected by three reviewers. Risk of cancer was pooled to provide an adjusted odds ratio (OR) with a 95% confidence interval (CI). The primary outcome was the risk of developing cancer in ever versus non-antibiotic users. Cancer risk’s association with antibiotic intake was evaluated among 7,947,270 participants (n = 25 studies). Overall, antibiotic use was an independent risk factor for cancer occurrence (OR 1.18, 95%CI 1.12–1.24, p < 0.001). The risk was especially increased for lung cancer (OR 1.29, 95%CI 1.03–1.61, p = 0.02), lymphomas (OR 1.31, 95%CI 1.13–1.51, p < 0.001), pancreatic cancer (OR 1.28, 95%CI 1.04–1.57, p = 0.019), renal cell carcinoma (OR 1.28, 95%CI 1.1–1.5, p = 0.001), and multiple myeloma (OR 1.36, 95%CI 1.18–1.56, p < 0.001). There is moderate evidence that excessive or prolonged use of antibiotics during a person’s life is associated with slight increased risk of various cancers. The message is potentially important for public health policies because minimizing improper antibiotic use within a program of antibiotic stewardship could also reduce cancer incidence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers11081174

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 43

  1. Ubeda, 2012, Antibiotics, microbiota, and immune defense, Trends Immunol., 33, 459, 10.1016/j.it.2012.05.003 · DOI · Paper page
  2. Stroup, 2000, Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group, JAMA, 283, 2008, 10.1001/jama.283.15.2008 · DOI · Paper page
  3. Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 · DOI · Paper page
  4. Akre, 2000, Risk for gastric cancer after antibiotic prophylaxis in patients undergoing hip replacement, Cancer Res., 60, 6376
  5. Boursi, 2015, Recurrent antibiotic exposure may promote cancer formation--Another step in understanding the role of the human microbiota?, Eur. J. Cancer, 51, 2655, 10.1016/j.ejca.2015.08.015 · DOI · Paper page
  6. Tamim, 2008, Risk of breast cancer in relation to antibiotic use, Pharmacoepidemiol. Drug Saf., 17, 144, 10.1002/pds.1512 · doi:10.1002/pds.1512
  7. Boursi, 2015, Impact of antibiotic exposure on the risk of colorectal cancer, Pharmacoepidemiol. Drug Saf., 24, 534, 10.1002/pds.3765 · DOI · Paper page
  8. Busby, 2017, The effect of medications which cause inflammation of the gastro-oesophageal tract on cancer risk: A nested case-control study of routine Scottish data, Int. J. Cancer, 140, 1828, 10.1002/ijc.30612 · DOI
  9. Chang, 2005, Medication use and risk of non-Hodgkin’s lymphoma, Am. J. Epidemiol., 162, 965, 10.1093/aje/kwi311 · DOI
  10. Daniels, N.A., Chen, Y.H., and Bent, S. (2009). Antibiotic and anti-inflammatory use and the risk of prostate cancer. BMC Res. Notes, 2. · doi:10.1186/1756-0500-2-57
  11. Dik, 2016, Frequent Use of Antibiotics Is Associated with Colorectal Cancer Risk: Results of a Nested Case-Control Study, Dig. Dis. Sci., 61, 255, 10.1007/s10620-015-3828-0 · DOI
  12. Fall, 2006, Antibiotic treatment and risk of gastric cancer, Gut, 55, 793, 10.1136/gut.2006.091850 · doi:10.1136/gut.2006.091850
  13. Friedman, 2006, Antibiotics and risk of breast cancer: Up to 9 years of follow-up of 2.1 million women, Cancer Epidemiol. Biomark. Prev., 15, 2102, 10.1158/1055-9965.EPI-06-0401 · DOI · Paper page
  14. 2005, Use of antibiotics and risk of breast cancer, Am. J. Epidemiol., 161, 616, 10.1093/aje/kwi087 · DOI
  15. Kato, 2003, History of antibiotic use and risk of non-Hodgkin’s lymphoma (NHL), Int. J. Cancer, 107, 99, 10.1002/ijc.11356 · DOI
  16. Kaye, 2005, Antibiotics and the risk of breast cancer, Epidemiology, 16, 688, 10.1097/01.ede.0000172131.84877.42 · DOI
  17. Kilkkinen, 2008, Antibiotic use predicts an increased risk of cancer, Int. J. Cancer, 123, 2152, 10.1002/ijc.23622 · DOI · Paper page
  18. Rasmussen, 2012, Antibiotic use and risk of non-Hodgkin lymphomas, Int. J. Cancer, 131, E1158, 10.1002/ijc.27626 · doi:10.1002/ijc.27626
  19. Russell, B., Garmo, H., Beckmann, K., Stattin, P., Adolfsson, J., and Van Hemelrijck, M. (2018). A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0. PLoS ONE, 13. · DOI
  20. Tamim, 2011, Antibiotic use and risk of gynecological cancer, Eur. J. Obstet. Gynecol. Reprod. Biol., 159, 388, 10.1016/j.ejogrb.2011.06.018 · DOI
  21. Velicer, 2004, Antibiotic use in relation to the risk of breast cancer, JAMA, 291, 827, 10.1001/jama.291.7.827 · DOI · Paper page
  22. Sorensen, 2005, Use of antibiotics and risk of breast cancer: A population-based case-control study, Br. J. Cancer, 92, 594, 10.1038/sj.bjc.6602313 · DOI
  23. Yang, 2016, Associations of antibiotic use with risk of primary liver cancer in the Clinical Practice Research Datalink, Br. J. Cancer, 115, 85, 10.1038/bjc.2016.148 · DOI
  24. Zhang, 2008, Antibiotic use and the risk of lung cancer, Cancer Epidemiol. Biomark. Prev., 17, 1308, 10.1158/1055-9965.EPI-07-2817 · DOI
  25. Tamim, 2010, Association between antibiotic use and risk of prostate cancer, Int. J. Cancer, 127, 952, 10.1002/ijc.25139 · DOI
  26. Didham, 2005, Antibiotic exposure and breast cancer in New Zealand, Breast Cancer Res. Treat., 92, 163, 10.1007/s10549-005-2115-8 · doi:10.1007/s10549-005-2115-8
  27. Wang, 2014, Infection, antibiotic therapy and risk of colorectal cancer: A nationwide nested case-control study in patients with Type 2 diabetes mellitus, Int. J. Cancer, 135, 956, 10.1002/ijc.28738 · DOI · Paper page
  28. Knekt, 2000, Does antibacterial treatment for urinary tract infection contribute to the risk of breast cancer?, Br. J. Cancer, 82, 1107, 10.1054/bjoc.1999.1047 · DOI
  29. Yang, 2017, Antibiotic-Induced Changes to the Host Metabolic Environment Inhibit Drug Efficacy and Alter Immune Function, Cell Host Microbe, 22, 757, 10.1016/j.chom.2017.10.020 · DOI · Paper page
  30. Sergentanis, 2010, Is antibiotic use a risk factor for breast cancer? A meta-analysis, Pharmacoepidemiol. Drug Saf., 19, 1101, 10.1002/pds.1986 · DOI
  31. Khosravi, 2013, Disruption of the gut microbiome as a risk factor for microbial infections, Curr. Opin. Microbiol., 16, 221, 10.1016/j.mib.2013.03.009 · DOI · Paper page
  32. Aragon, 2018, The Urinary Tract Microbiome in Health and Disease, Eur. Urol. Focus, 4, 128, 10.1016/j.euf.2016.11.001 · DOI · Paper page
  33. Mao, 2018, Interplay between the lung microbiome and lung cancer, Cancer Lett., 415, 40, 10.1016/j.canlet.2017.11.036 · DOI · Paper page
  34. Whiteside, 2015, The microbiome of the urinary tract—A role beyond infection, Nat. Rev. Urol., 12, 81, 10.1038/nrurol.2014.361 · DOI · Paper page
  35. Yamamoto, 2014, Intestinal microbiome and lymphoma development, Cancer J., 20, 190, 10.1097/PPO.0000000000000047 · DOI
  36. Mima, 2017, The microbiome and hepatobiliary-pancreatic cancers, Cancer Lett., 402, 9, 10.1016/j.canlet.2017.05.001 · DOI
  37. Zhu, 2016, Chlamydia Trachomatis Infection-Associated Risk of Cervical Cancer: A Meta-Analysis, Medicine, 95, e3077, 10.1097/MD.0000000000003077 · DOI · Paper page
  38. Langdon, 2016, The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation, Genome Med., 8, 39, 10.1186/s13073-016-0294-z · DOI · Paper page
  39. Durand, 2005, Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge, J. Clin. Microbiol., 43, 5588, 10.1128/JCM.43.11.5588-5592.2005 · DOI · Paper page
  40. Fasugba, O., Gardner, A., Mitchell, B.G., and Mnatzaganian, G. (2015). Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: A systematic review and meta-analysis of observational studies. BMC Infect. Dis., 15. · DOI · Paper page
  41. Park, 2018, Intestinal microbiota, chronic inflammation, and colorectal cancer, Intest. Res., 16, 338, 10.5217/ir.2018.16.3.338 · DOI
  42. Meeker, 2016, Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices: A Randomized Clinical Trial, JAMA, 315, 562, 10.1001/jama.2016.0275 · DOI · Paper page
  43. Sikkens, 2017, Behavioral Approach to Appropriate Antimicrobial Prescribing in Hospitals: The Dutch Unique Method for Antimicrobial Stewardship (DUMAS) Participatory Intervention Study, JAMA Intern. Med., 177, 1130, 10.1001/jamainternmed.2017.0946 · DOI

Cited by

See all 106

Metadata

Authors
Petrelli, F., Ghidini, M., Ghidini, A., Perego, G., Cabiddu, M., Khakoo, S., Oggionni, E., Abeni, C., Hahne, J. C., Tomasello, G., & Zaniboni, A.
Venue
Cancers
Publisher
MDPI AG
Published
2019-08-14
Volume
11
Issue
8
Pages
1174
ISSN
2072-6694 (ISSN-L)
OpenAlex
W2967544221
Cited by
106
References
10
FWCI
2.21
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.